Sandra A Mitchell - JoVE Visualize

Showing results (111-120 of 149) with videos related to

Pageof 15

Sort By:

European Journal of Oncology Nursing : the Official Journal of European Oncology Nursing Society|August 2, 2025

Advancing global cancer symptom science: Insights and strategies from the inaugural Cancer Symptom Science Expert MeetingSara Colomer-Lahiguera, Rachel A Pozzar, Carolyn S Harris, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 29, 2017

Clinical Activity of the γ-Secretase Inhibitor PF-03084014 in Adults With Desmoid Tumors (Aggressive Fibromatosis)Shivaani Kummar, Geraldine O'Sullivan Coyne, Khanh T Do, et al.

Cancer|April 29, 2025

A framework-based guide for adapting and implementing primary care-based pediatric interventions to the pediatric oncology setting: HPV PROTECT as an exemplarJames L Klosky, Brooke Cherven, Melissa B Gilkey, et al.

Cancer|March 29, 2016

Cognitive testing of tobacco use items for administration to patients with cancer and cancer survivors in clinical researchStephanie R Land, Graham W Warren, Jennifer L Crafts, et al.

Bone Marrow Transplantation|February 2, 2021

Predictors of hematologic malignancy relapse in patients with advanced chronic graft-versus-host diseaseClaire L Ruben, Filip Pirsl, Seth M Steinberg, et al.

Journal of Pain and Symptom Management|March 3, 2026

Effect of a Symptom Surveillance and Collaborative Care Intervention on Palliative Care UtilizationDeirdre R Pachman, Kathryn J Ruddy, Joan M Griffin, et al.

Implementation Science Communications|November 29, 2023

The Longitudinal Implementation Strategy Tracking System (LISTS): feasibility, usability, and pilot testing of a novel methodJustin D Smith, Wynne E Norton, Sandra A Mitchell, et al.

Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|July 23, 2013

Cognitive interviewing of the US National Cancer Institute's Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)Jennifer L Hay, Thomas M Atkinson, Bryce B Reeve, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 15, 2017

Use of PRO Measures to Inform Tolerability in Oncology Trials: Implications for Clinical Review, IND Safety Reporting, and Clinical Site InspectionsJanice Kim, Harpreet Singh, Kassa Ayalew, et al.

Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 23, 2015

Measuring therapeutic response in chronic graft-versus-host disease. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: IV. The 2014 Response Criteria Working Group reportStephanie J Lee, Daniel Wolff, Carrie Kitko, et al.

Pageof 15

Showing results (111-120 of 149) with videos related to

Sort By:

Pageof 15

European Journal of Oncology Nursing : the Official Journal of European Oncology Nursing Society|August 2, 2025

Advancing global cancer symptom science: Insights and strategies from the inaugural Cancer Symptom Science Expert MeetingSara Colomer-Lahiguera, Rachel A Pozzar, Carolyn S Harris, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 29, 2017

Clinical Activity of the γ-Secretase Inhibitor PF-03084014 in Adults With Desmoid Tumors (Aggressive Fibromatosis)Shivaani Kummar, Geraldine O'Sullivan Coyne, Khanh T Do, et al.

Cancer|April 29, 2025

A framework-based guide for adapting and implementing primary care-based pediatric interventions to the pediatric oncology setting: HPV PROTECT as an exemplarJames L Klosky, Brooke Cherven, Melissa B Gilkey, et al.

Cancer|March 29, 2016

Cognitive testing of tobacco use items for administration to patients with cancer and cancer survivors in clinical researchStephanie R Land, Graham W Warren, Jennifer L Crafts, et al.

Bone Marrow Transplantation|February 2, 2021

Predictors of hematologic malignancy relapse in patients with advanced chronic graft-versus-host diseaseClaire L Ruben, Filip Pirsl, Seth M Steinberg, et al.

Journal of Pain and Symptom Management|March 3, 2026

Effect of a Symptom Surveillance and Collaborative Care Intervention on Palliative Care UtilizationDeirdre R Pachman, Kathryn J Ruddy, Joan M Griffin, et al.

Implementation Science Communications|November 29, 2023

The Longitudinal Implementation Strategy Tracking System (LISTS): feasibility, usability, and pilot testing of a novel methodJustin D Smith, Wynne E Norton, Sandra A Mitchell, et al.

Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|July 23, 2013

Cognitive interviewing of the US National Cancer Institute's Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)Jennifer L Hay, Thomas M Atkinson, Bryce B Reeve, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 15, 2017

Use of PRO Measures to Inform Tolerability in Oncology Trials: Implications for Clinical Review, IND Safety Reporting, and Clinical Site InspectionsJanice Kim, Harpreet Singh, Kassa Ayalew, et al.

Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 23, 2015

Measuring therapeutic response in chronic graft-versus-host disease. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: IV. The 2014 Response Criteria Working Group reportStephanie J Lee, Daniel Wolff, Carrie Kitko, et al.

Pageof 15